Latest Regulatory News

Galileo Mining Ltd has responded to an ASX price and volume query, confirming no undisclosed material information exists to explain recent trading activity. The company attributes the surge to positive market sentiment around its Norseman Project and lithium joint venture with Mineral Resources.

Coast Entertainment reports a robust first half of FY26 with significant growth in ticket sales and visitation, driven by new attractions and strong promotional campaigns. The Group also strengthens its financial position amid ongoing economic challenges.

Star Minerals has received mining approval for its Tumblegum South Gold Project and commenced grade control drilling, setting the stage for production in early 2026 amid rising gold prices.

Imricor Medical Systems has secured Virginia Commonwealth University Health as the third US site for its VISABL-AFL clinical trial, advancing its FDA approval pathway for MRI-guided cardiac ablation technology.

Paladin Energy reports a strong production ramp-up at its Langer Heinrich Mine and confirms robust progress on the Patterson Lake South project, supported by a strengthened balance sheet and a positive uranium market outlook.

Australian Strategic Materials and Energy Fuels are set to discuss their proposed acquisition in a joint webcast, offering investors a closer look at this strategic move.

Energy Fuels Inc. has announced a proposed acquisition of Australian Strategic Materials (ASM) valued at approximately A$447 million, aiming to establish a leading Western rare earths and critical minerals producer with a fully integrated supply chain.

Energy Fuels Inc. has announced a binding agreement to acquire Australian Strategic Materials Ltd (ASM) in a deal valuing ASM at approximately A$447 million, offering shareholders a 121% premium. The acquisition aims to establish a vertically integrated Western rare earths supply chain, aligning with critical minerals strategies between the US and Australia.

Tivan Limited has made significant strides in its critical minerals portfolio, securing a $51.3 million strategic investment and progressing key feasibility studies across multiple projects.

BCAL Diagnostics has launched its Avantect pancreatic and ovarian cancer tests in Australia, alongside expanding clinical data and establishing a national registry for its BREASTESTplus breast cancer test.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

Australian Mines Limited has reported promising initial assay results from its 2025 drilling campaign at the Boa Vista Gold Project in Brazil, confirming broad and continuous gold mineralisation with significant high-grade zones.